Li Shizhen Pharmaceutical Group was officially established in 2002. It is located in Qichun, Hubei, the hometown of the Medical Saint Li Shizhen. It has now developed into a series of major health products such as the cultivation of authentic medicinal materials, Chinese patent medicines, Chinese herbal medicine tablets, Chinese herbal formula granules, health wine, Qi Ai series of big health products A full-industry chain group company integrating production, R&D, pharmaceutical wholesale and retail, pharmaceutical culture and tourism, moxibustion, massage and other traditional Chinese medicine suitable technical training. The group is a high-tech enterprise in Hubei Province, a pharmaceutical GMP inspector training base in Hubei Province, a college graduate employment internship base in Hubei Province, and a graduate work station in Central China Agricultural University.

The group has two major production bases, "Hubei Qichun Compendium Materia Medica Biotechnology Park", "Xiamen Meishang Pharmaceutical Haicang Factory Area", and "Hubei Wuhan Taiwan Biotechnology Industrial Park" (Medical Flow Park), with 8 holding subsidiaries. , has 20 pharmaceutical production dosage forms, 185 national drug approval documents, 23 dosage forms and production license items that have passed the national GMP certification, 22 production workshops, a factory area of ​​150,000 square meters, and an annual production capacity of 6 billion yuan. Now, more than 100 Chinese patent medicine varieties are mainly produced, of which more than 40 basic medicine varieties can be included in the medical insurance catalog; more than 350 Chinese medicine formula granules are produced; more than 700 authentic Chinese herbal medicine varieties are produced and operated, and more than 100 Qi Ai products are produced.

The group takes the Hubei Provincial Traditional Chinese Medicine Resource Application Engineering Technology Research Center awarded by the Hubei Provincial Department of Science and Technology as an innovative research and development platform, and has joined hands with 15 domestic scientific research institutes and universities to carry out extensive cooperation in industry, academia and research to build the company's high-level scientific research platform. There are currently 7 major laboratories, equipped with more than 200 sets of various scientific research facilities and equipment, and nearly 100 technical support personnel engaged in scientific research and R&D. They can conduct trial production of products such as medicines, food, cosmetics, disinfection products, medical devices, and wormwood products. There are more than 1,100 standard formulation, stability inspection and performance testing projects, and a series of scientific research work such as trace detection, molecular structure confirmation, bactericidal ability confirmation, trace element and content analysis and detection can also be carried out. More than 50 million yuan of R&D expenses are invested every year, nearly 10 national and provincial scientific research projects have been approved, more than 30 patents have been obtained, and 8 provincial and municipal scientific and technological progress awards have been won. The developed traditional Chinese medicine formula granules have been included in the production pilot project by Hubei Province.

The group has established more than 800 terminal marketing service offices, with sales networks all over the country. The group owns brands such as "Compendium of Materia Medica", "Li Shizhen", "Qi Ai" and "Jia Fang".

The group established the production concept of "using authentic medicinal materials and making scientific Chinese medicine", and always regarded the fields as the production workshop of the enterprise, standardized the entire production process from the source, strictly abide by the GAP standards, and established Coptis chinensis, Magnolia officinalis, Sydney, Sichuan shellfish, There are more than 100 mu of authentic medicinal materials bases of more than 100 varieties of Qi Ai and Xia Dust Grass.